Specifically, in pathological conditions such as diabetic kidney disease, the interaction between NgBR and sNogo‐B plays an important role in vascular remodelling through dampening VEGF‐A signalling and reducing eNOS, Akt and GSK3β phosphorylation, which in some extent different from the physiological conditions.19 Here, NUS1 is linked to diabetic kidney disease.